Press Release: ROSEN, A RANKED AND LEADING LAW FIRM, Encourages KBR, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – KBR
NEW YORK, Oct. 25, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of KBR, Inc. (NYSE: KBR) between May 6, 2025 and June 19, 2025, both dates inclusive (the “Class Period”), of the important November 18, 2025 lead plaintiff deadline in the securities class action…
DFY Vending Logo BOCA RATON, Fla., Oct. 25, 2025 (GLOBE NEWSWIRE) -- DFY Vending, a leading U.S.-based provider of Done-For-You vending machine solutions, announced today the nationwide expansion of its popular Vending Machines program, bringing a turnkey passive income opportunity to more investors than ever before. This milestone reflects DFY Vending’s continued commitment to offering…
– 100% responspercentage in 1L linkszijdige mCRC (n=8, bevestigd en onbevestigd) – 62% responspercentage in 2L links- en rechtszijdige mCRC (n=13, bevestigd en onbevestigd) UTRECHT, Nederland en CAMBRIDGE, Massachusetts, Oct. 25, 2025 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq: MRUS) (Merus, het Bedrijf, wij of ons/onze), een oncologiebedrijf dat innovatieve, multispecifieke full-length antilichamen en antilichaam-geneesmiddelconjugaten (Biclonics®, Triclonics® en…
Austin, Texas, October 25, 2025 – ITM Isotope Technologies Munich SE (ITM), a leading radiopharmaceutical biotech company, announced analyses data from its Phase 3 COMPETE trial in patients with Grade 1 or Grade 2 somatostatin receptor (SSTR)-positive gastroenteropancreatic neuroendocrine tumors (GEP-NETs). Results showed consistently higher objective response rates (ORR) and longer progression-free survival (PFS) across…
New York, New York, USA, Oct. 24, 2025 (GLOBE NEWSWIRE) -- Aletheia Capital Endeavours (ACE) today announced the launch of RepIntel, a precision field-intelligence platform designed to close one of healthcare’s most persistent gaps: the failure of lifesaving therapies to reach the patients they were created for.
Thu, 04 Sep 2025 05:00:00 GMT NEW YORK, Sept. 04, 2025 (GLOBE NEWSWIRE) -- StoneX Commodity Solutions (SCS), a subsidiary of StoneX Group Inc. (NASDAQ: SNEX) ("StoneX"), announced today the completion of its acquisition of Right ...
